AKAndrew J. Kirsch

Andrew J. Kirsch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew J. Kirsch has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Current practices and challenges in managing bedwetting: A multinational survey of pediatricians

    by Elizabeth Chu, Vanessa Aponte, Rachael Germany, Jared Kirsch, Suhas Penukonda, Benjamin Press, Anna Bujons, Cristian Sager, Ubirajara Barroso, Andrew J. Kirsch

  • Clinical manifestations and management of prune-belly syndrome: A 20-year single center experience

    by Elizabeth Chu, Benjamin Press, Corey Weinstein, Angela M. Arlen, Edwin A. Smith, Andrew J. Kirsch


  • Early spontaneous resolution of vesicoureteral reflux from voiding cystourethrogram: A comparison of contemporary prediction models

    by Adree Khondker, Jin Kyu Kim, Angela M. Arlen, Mandy Rickard, Michael E. Chua, Andrew J. Kirsch, Armando J. Lorenzo, Christopher S. Cooper

  • Open Access

    Use of ChatGPT in Pediatric Urology and its Relevance in Clinical Practice: Is it useful?

    by Antonio Vitor Nascimento Martinelli Braga, Noel Charlles Nunes, Emanoel Nascimento Santos, Maria Luiza Veiga, Ana Aparecida Nascimento Martinelli Braga, Glicia Estevam de Abreu, Jose Bessa, Luis Henrique Braga, Andrew J Kirsch, Ubirajara Barroso

    Introduction: Artificial intelligence (AI) can be described as the combination of computer sciences and linguistics, objective building machines capable of performing various tasks that otherwise would need Human Intelligence. One of the many AI based tools that has gained popularity is the Chat-Generative Pre-Trained Transformer (ChatGPT). Due to the popularity and its massive media coverage, incorrect and misleading information provided by ChatGPT will have a profound impact on patient misinformation. Furthermore, it may cause mistreatment and misdiagnosis as ChatGPT can mislead physicians on the decision-making pathway. Objective: Eevaluate and assess the accuracy and reproducibility of ChatGPT answers regarding common pediatric urological diagnoses. Methods: ChatGPT 3.5 version was used. The questions asked for the program involved Primary Megaureter (pMU), Enuresis and Vesicoureteral Reflux (VUR). There were three queries for each topic, adding up to 9 in total. The queries were inserted into ChatGPT twice, and both responses were recorded to examine the reproducibility of ChatGPT’s answers. After that analysis, both questions were combined, forming a single answer. Afterwards, those responses were evaluated qualitatively by a board of three specialists with a deep expertise in the field. A descriptive analysis was performed. Results: ChatGPT demonstrated general knowledge on the researched topics, including the definition, diagnosis, and treatment of Enuresis, VUR and pMU. Regarding Enuresis, the provided definition was partially correct, as the generic response allowed for misinterpretation. As for the definition of VUR, the response was considered appropriate. And for pMU it was partially correct, lacking essential aspects of its definition such as the diameter of the dilatation of the ureter. Unnecessary exams were suggested, for both Enuresis and pMU. Regarding the treatment of the conditions mentioned, it specified treatments to Enuresis that are known to be ineffective, such as bladder training. Discussion: AI has a wide potential to bring several benefits to medical knowledge, improving decision-making and patient education. However, following the reports on the literature, we found a lack of genuine clinical experience and judgment from ChatGPT, performing well in less complex questions, yet with a steep decrease on its performance as the complexity of the queries increase. Therefore, providing wrong answers to crucial topics. Conclusion: ChatGPT responses present a combination of accurate and relevant information, but also incomplete, ambiguous and, occasionally, misleading details, especially regarding the treatment of the investigated diseases. Because of that, it is not recommended to make clinical decisions based exclusively on ChatGPT.


  • Open Access

    Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux

    by Michelle Lightfoot, Aylin N. Bilgutay, Noah Tollin, Scott Eisenberg, Jake Weiser, Leah Bryan, Edwin Smith, James Elmore, Hal Scherz, Andrew J. Kirsch

    Purpose: Endoscopic dextranomer/hyaluronic acid (Dx/HA) injection is a common treatment for vesicoureteral reflux (VUR) with excellent reported short-term clinical success rates. Long-term outcomes are less well-defined. We assessed long-term outcomes and parental satisfaction after Dx/HA injection for primary VUR with >5-year follow-up. Materials and Methods: Families of all patients who underwent Dx/HA injection for primary VUR at our institution between 2008 and 2012 were contacted for telephone interview. Data collected by phone included parental satisfaction and presence and severity of UTIs pre-operatively and post-operatively. Patient demographics, radiographic VUR data, need for secondary surgery, and surgical indications were obtained through chart review. Results: Five hundred and seventy-five patients underwent Dx/HA injection for primary VUR between 2008 and 2012. Ninety-nine (17.2%) of these patients' parents were successfully contacted and interviewed. Median follow-up time from surgery to survey was 8.4 (IQR 6.8–9.6) years. Secondary surgery was performed in 13/99 (13.1%), most commonly repeat Dx/HA injection. Seven patients (7.1%) underwent secondary Dx/HA injection for persistent VUR without UTIs at a median of 0.35 (IQR 0.33–0.77) years post-operatively. Five patients (5.1%) underwent Dx/HA injection (n = 3) or ureteral reimplantation (n = 2) for VUR with febrile UTIs (fUTIs) at a median of 2.2 (IQR 1.3–5.1) years. One patient had ureteral reimplantation for symptomatic obstruction 2.8 years after initial surgery. Only 3/99 (3.0%) required open or laparoscopic surgery after Dx/HA injection. Eighty-three families (84.7%) reported ≥1 fUTIs pre-operatively. Of these, only 9/83 (10.8%) reported fUTIs post-operatively, for an overall clinical success rate of 89.2%. Clinical success was 93.1% in patients whose pre-operative fUTIs were treated outpatient and 80.0% in those hospitalized at least once for fUTI treatment pre-operatively. Ninety-four percent of parents were highly satisfied, 2.4% partially satisfied, and 3.5% dissatisfied. Conclusions: Endoscopic injection with Dx/HA for primary VUR appears to have good long-term clinical success rates and high parental satisfaction, mirroring our previously reported short-term results. Post-operative ureteral obstruction is rare but may occur years post-operatively, justifying initial sonographic surveillance, and repeat imaging in symptomatic patients.


  • Vesicoureteral Reflux Index: Predicting Primary Vesicoureteral Reflux Resolution in Children Diagnosed after Age 24 Months

    by Michael Garcia-Roig, Derrick E. Ridley, Courtney McCracken, Angela M. Arlen, Christopher S. Cooper, Andrew J. Kirsch

    The Vesicoureteral Reflux Index is a validated tool that reliably predicts spontaneous resolution of reflux or at least 2 grades of improvement for patients diagnosed before age 24 months. We evaluated the Vesicoureteral Reflux Index in children older than 2 years. Patients younger than 18 years who were diagnosed with primary vesicoureteral reflux after age 24 months and had undergone 2 or more voiding cystourethrograms were identified. Disease severity was scored using the Vesicoureteral Reflux Index, a 6-point scale based on gender, reflux grade, ureteral abnormalities and reflux timing. Proportional subdistribution hazard models for competing risks identified variables associated with resolution/improvement at different time points. A total of 21 males and 250 females met inclusion criteria. Mean ± SD age was 4.0 ± 2.1 years and patients had a median vesicoureteral reflux grade of 2. The Vesicoureteral Reflux Index score improved by 1 point in 1 patient (100%), 2 points in 25 (67.6%), 3 points in 48 (37%), 4 points in 18 (21.4%) and 5 to 6 points in 4 (18.2%). Female gender (p = 0.005) and vesicoureteral reflux timing (late filling, p = 0.002; early/mid filling, p <0.001) independently predicted nonresolution. Median resolution time based on Vesicoureteral Reflux Index score was 2 months or less in 15.6% of patients (95% CI 11.0-13.8), 3 months in 34.7% (95% CI 25.4-44.1), 4 months in 55.9% (95% CI 40.1 to infinity) and 5 months or more in 30.3% (95% CI 29.5 to infinity). High grade (IV or V) reflux was not associated with resolution at any point. Ureteral abnormalities were associated with lack of resolution in the first 12 to 18 months (HR 0.29, 95% CI 0.29-0.80) but not in later followup. Vesicoureteral Reflux Index scores of 3, 4 and 5 were significantly associated with lack of resolution/improvement compared to scores of 2 or less (p = 0.031). The Vesicoureteral Reflux Index reliably predicts primary vesicoureteral reflux improvement/resolution in children diagnosed after age 24 months. Spontaneous resolution/improvement is less likely as Vesicoureteral Reflux Index score and time from diagnosis increase.